Abstract: Psychotic symptoms are treated by the administration of drugs which amplify the ability of natural stimulators of AMPA receptors to enhance the mediation of excitatory synaptic response. What is previously known about the activity and effectiveness of these drugs is unrelated to the etiology of psychotic symptoms. The invention finds particular utility in the treatment of schizophrenia.
Type:
Grant
Filed:
August 30, 1995
Date of Patent:
June 30, 1998
Assignees:
Gary A. Rogers, The Regents of the University of California
Inventors:
John Larson, Gary Lynch, Gary A. Rogers